Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration
February 26, 2010
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Eye advance online publication 12 February 2010; doi: 10.1038/eye.2010.9
Purpose: To assess the 1-year functional outcome and to evaluate the morphological changes after intravitreal injections of ranibizumab in eyes affected with retinal angiomatous proliferation (RAP) due to age-related macular degeneration (AMD).
